neoGEN-Series®

Electric Cell Signaling System

The neoGEN-Series® system is a state-of-the art, technically-innovative medical device for producing electric cell signaling energy waves (EcST and ESI).

The system is used to successfully treat circulatory issues, all types of acute and chronic pain, long-term (intractable) pain and drug-resistant pain. The neoGEN-Series® also offers specific-parameter signaling for efficacious neuromuscular reeducation, muscle strengthening and relaxation of muscle spasm activity.

The RST-Sanexas neoGEN-Series® medical device is the original and only electric cell signaling device that was used in clinical research, published in multiple medical journals proving the ability to effect nerves and reduce painful symptoms associated with peripheral neuropathy.

More than 30 published medical reports are available by written request  covering painful neuropathic conditions, and muscular neuromuscular reeducation.  RST-Sanexas neoGEN-Series® system is safe, effective, user-friendly and reimbursed, even by Medicare. 

Electric Cell Signaling Reported Clinical Benefits

Applications and Electric Cell Signaling protocols have been subjected to clinical trails.  The results have been published in numerous academic, scientific and medical publications and literature. The technologies efficacy is amply demonstrated by these published results and is reinforced anecdotally, through the testimonials of thousands of patients.

Clinical Benefits

  • Safe, effective, non-invasive and user-friendly reimbursable treatment
  • Minimal potential for side effects, easily avoided
  • Extremely high patient compliance, outcome and satisfaction
  • Substantial reduction in out-bound patient referrals

FDA Clinical Indications

  • Management and symptomatic relief of chronic (long-term) INTRACTABLE pain
  • Adjunctive treatment of post-traumatic pain syndromes
  • Adjunctive treatment in the management of post-surgical pain conditions
  • Relaxation of muscle spasms
  • Neuro-muscular reeducation
  • Prevention or retardation of disuse atrophy
  • Maintaining or increasing range of motion
  • Increasing local circulation
  • Immediate post-surgical stimulation of calf muscles to prevent phlebothrombosis
We need a nice verbatuam placed in here that promotes the value of the system and the benefits that they have seen in their practice and within their patient population.

- Peter M. Carney, M.D., F.A.A.NS
Technology
Our technology is backed by over 30 patient studies

About Electric Cell Signaling Treatments

Electric cell signaling treatment (EcST) refers to the use of electronic signal energy waves produced by an ultra-high digital frequency generator (UHdfg). These therapeutic pulsed energy waves are comfortably and non-invasively delivered directly into the body’s desired anatomical region.

The neoGEN-Series® system has numerous published medical journal reports and studies involving the successful treatment of multiple medical indications, syndromes and neurogenic pain conditions.

The neoGEN-Series® system is the original (and only) EcST medical system that was clinically utilized with the documented and published Combined Electrochemical Treatment (CET) protocol.

Treatments with the RST-Sanexas neoGEN-Series® can be 100% reimbursed.  
Treatments with the RST-Sanexas neoGEN-Series® can be 100% reimbursed.  
SPECIFICATIONS
4 Channel Unit  
  • Ultra-high digital frequency generator
  • Hospital power cable
  • 5-way patient lead cable
  • Set-patient pin lead wires
  • Reusable carbon/graphite electrodes w/viscose (4)
  • Electrode fixation Wraps (24”)
neoGEN VPX  
  • Venturi vacuum cup electrodes w/viscose (8)
  • Vacuum electrode tubes (8)
  • Interconnect cable Mains power cable
  • Deluxe Hospital Grade Modality Cart
Deluxe Hospital Grade Modality Cart